If augmented by TLR-4 driven eosinophilia as observed in AMP-LPS treated mice, these findings suggest AMP-LPS as a stronger stimulus for allergic inflammation in the airways over LPS alone. This evidence concerns the gene TLR4 and Increased total eosinophil count.